Growth hormone (GH) is a growth-promoting and metabolic hormone that also exhibits features common to cytokines. Metabolically, GH acutely exhibits insulin-like effects (eg., glucose uptake), but with chronic exposure promotes a state of cellular and whole-body insulin resistance (a diabetogenic effect). Like many cytokines, in certain cells GH activates transcription factors called STATs that rapidly induce particular genes. One of these STATs, activated by GH in some cells, but not others, is STAT3, an important mediator of acute inflammatory responses. At a molecular level, GH signalling is initiated by activation of the cytoplasmic kinase, JAK2, which promotes tyrosine phosphorylation of various cellular proteins including insulin receptor substrate-1 (IRS-1) -- a key component of the insulin signalling pathway -- and STATs. We propose to extend our established expertise in studies of tyrosine phosphorylation and GH receptor signalling to investigate molecular mechanisms underlying: a) GH- induced insulin resistance; and b) regulation of GH-induced STAT3 activation.
Our specific aims are: 1. Map regions of the GHR, JAK2, and IRS2, and IRS-1 (and IRS-2) necessary for IRS physical and functional interaction with the GHR- JAK2 complex. 2. Using cell lines stably expressing the GHR and JAK2 with or without IRS-2, assess the impact of the presence of IRS proteins on GH-induced phosphatidylinositol-3 kinase (PI-3 K) activation, JAK2 activation, cell proliferation, and glucose transporter translocation. 3. Develop a cell-based model of GH-induced insulin resistance in murine adipocytes and in stably transfected non-adipocyte cell lines expressing combinations of the GHR, JAK2, IRS molecules, and insulin receptor (IR) to test the effects of GH-induced tyrosine (and perhaps serine/threonine) phosphorylation events on IR signalling. 4. Assess the degree to which GH-induced STAT3 activation is attributable to autophosphorylation of particular JAK2 tyrosine residues and whether this process can be specifically influenced by the level of protein tyrosine phosphatase activation. These studies are relevant to understanding: a) the insulin resistance common to NIDDM; and b) the nature of the inflammatory state and body's response to tissue injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046395-08
Application #
6176213
Study Section
Endocrinology Study Section (END)
Program Officer
Sato, Sheryl M
Project Start
1993-05-01
Project End
2001-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
8
Fiscal Year
2000
Total Cost
$207,468
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Liu, Ying; Zhang, Yue; Jiang, Jing et al. (2016) GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers. Mol Endocrinol 30:504-17
Chen, Hainan; Kleinberger, Jeffrey W; Takane, Karen K et al. (2015) Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human ?-Cells. Diabetes 64:3784-97
Gan, Yujun; Paterson, Andrew J; Zhang, Yue et al. (2014) Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells. Endocrinology 155:1000-9
Liu, Ying; Berry, Philip A; Zhang, Yue et al. (2014) Dynamic analysis of GH receptor conformational changes by split luciferase complementation. Mol Endocrinol 28:1807-19
Zhao, Yueshui; Xiao, Xiaoqiu; Frank, Stuart J et al. (2014) Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-?, and IL-1?. Am J Physiol Endocrinol Metab 307:E186-98
Gan, Yujun; Buckels, Ashiya; Liu, Ying et al. (2014) Human GH receptor-IGF-1 receptor interaction: implications for GH signaling. Mol Endocrinol 28:1841-54
Zhang, Yuchao; Liu, Yuantao; Li, Xia et al. (2013) Effects of insulin and IGF-I on growth hormone- induced STAT5 activation in 3T3-F442A adipocytes. Lipids Health Dis 12:56
Gan, Yujun; Zhang, Yue; Buckels, Ashiya et al. (2013) IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity. Mol Endocrinol 27:1969-79
Zheng, Ying; Qin, Hongwei; Frank, Stuart J et al. (2011) A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. Blood 118:156-66
Li, Xin; Huang, Yao; Jiang, Jing et al. (2011) Synergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptors. Cell Signal 23:417-24

Showing the most recent 10 out of 14 publications